D-1424-2022 Class II Ongoing
FDA drug recall D-1424-2022 was initiated by Family Dollar Stores, Llc. on Jun 23, 2022 and is designated Class II. Reason for recall: CGMP Deviations: product held outside appropriate storage temperature conditions. The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 31, 2022
- Initiation Date
- Jun 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990 GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724 BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438 BAYER LOW DOSE 81 MG TABLET 120 CT SKU 916070 BAYER ASPIRIN 325MG TABLET 24CT SKU 913996 BAYER LOW DOSE TABLET 32CT SKU 915641 BAYER 81MG CHEWABLE TABLET 36 CT SKU 916078 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
Reason for Recall
CGMP Deviations: product held outside appropriate storage temperature conditions.
Distribution Pattern
Nationwide within the United States
Code Information
SKUs: 913990; 913724; 900438; 916070; 913996; 915641; 916078
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1424-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026